CHOLESTEROL-RICH APO-B CONTAINING LIPOPROTEINS AND SMOKING ARE INDEPENDENTLY ASSOCIATED WITH MACROVASCULAR DISEASE IN NORMOTENSIVE NIDDM PATIENTS

被引:8
作者
DEAN, JD
MATTHEWS, SB
DOLBEN, J
CAROLAN, G
LUZIO, S
OWENS, DR
机构
[1] Diabetes Research Unit, University of Wales College of Medicine, Cardiff
[2] Department of Bioengineering, University of Wales College of Medicine, Cardiff
[3] Department of Clinical Biochemistry, Llandough Hospital, Cardiff
关键词
NIDDM; MACROVASCULAR DISEASE; LIPOPROTEINS;
D O I
10.1111/j.1464-5491.1994.tb00347.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A cross-sectional study of macrovascular disease (MVD) and associated metabolic and other risk factors was conducted in 87 normotensive NIDDM patients. MVD was assessed by Rose questionnaire, 12 lead resting ECG, duplex scanning of carotid and peripheral vessels, and ankle:brachial systolic blood pressure ratio. Fasting serum total cholesterol, total triglycerides, LDL cholesterol, HDL cholesterol, apolipoproteins Al and B, lipoprotein (a), HbA1, plasma glucose, insulin, and C-peptide responses to a carbohydrate rich meal, body mass index (BMI), waist-hip ratio, urinary albumin excretion rate, blood pressure, smoking and family history were assessed as possible 'risk factors'. Apolipoprotein: lipid ratios were calculated to estimate lipoprotein composition. Thirty-six patients had demonstrable MVD. The presence of MVD was associated with higher total triglycerides (p < 0.05), BMI (p < 0.05), systolic blood pressure (p < 0.01), a lower apo B: non HDL cholesterol ratio (p < 0.001), and smoking (p < 0.005) but no other measures. Multiple regression analysis revealed smoking and a low apo B: non HDL cholesterol to be independently associated with MVD. The low apo B: non HDL cholesterol suggests a high cholesterol content of apo B containing lipoproteins. This lipoprotein abnormality is not a feature of NIDDM, but when present in these patients may be particularly atherogenic.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 41 条
[1]  
Panzram G., Mortality and survival in Type 2 (non‐insulin‐dependent) diabetes mellitus, Diabetologia, 30, pp. 123-131, (1987)
[2]  
Krolewski AS, Warram JH, Christlieb AR., Onset, course, complications, and prognosis of diabetes mellitus, Joslin's Diabetes Mellitus, pp. 251-277, (1985)
[3]  
Stolar M., Atherosclerosis in diabetes. The role of hyperin‐sulinaemia, Metabolism, 37, pp. 1-9, (1988)
[4]  
Stamler J., Vaccaro O., Neaton D., Wentworth D., Diabetes, other risk factors and 12 year mortality for men screened in the Multiple Risk Factor Intervention Trial, Diabetes Care, 16, pp. 434-444, (1993)
[5]  
Kannel WB, McGee DL, Diabetes and cardiovascular disease. The Framingham study, J Am Med Assoc, 241, pp. 2035-2038, (1979)
[6]  
Fontbonne A., Eschwege E., Cambien F., Richard JL, Ducimetiere P., Thibult N., Et al., Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11‐year follow‐up of the Paris Prospective Study, Diabetologia, 32, pp. 300-304, (1989)
[7]  
Morrish NJ, Stevens LK, Head J., Fuller JH, Jarrett RJ, Keen A., A prospective study of mortality among middle aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factors, Diabetologia, 33, pp. 542-548, (1990)
[8]  
Dall'aglio E., Strata A., Reaven G., Abnormal lipid metabolism in treated hypertensive patients with non‐insulin‐dependent diabetes mellitus, Am J Med, 84, pp. 899-903, (1988)
[9]  
Fuh MMT, Shieh SM, Wu DA, Chen YDI, Reaven GM, Abnormalities of carbohydrate and lipid metabolism in patients with hypertension, Arch Intern Med, 147, pp. 1035-1038, (1987)
[10]  
(1985)